Skip to main content

EKOS™ Endovascular System

OPTALYSE study

OPTALYSE long-term data

Sustained RV remodeling & improved patient outcomes

In the OPTALYSE study which evaluated the optimal dose/duration of EKOS treatment, patients were followed for one year. In addition to showing quick improvement in RV function, the long-term data showed sustained RV remodeling out to one-year. OPTALYSE was also the first study of an interventional pulmonary embolism (PE) treatment to show improvement in patient quality of life outcomes.1

 

RV function

RV/LV ratio continued to reduce after 48h

p value <030001@365d

Graph of RV/LV reduction after 48 hours

Endurance

Mean 6-minute walk test distance

Graph of 6-minute walk test to measure endurance over 1 year

Physical functioning

Mean PROMUS-PF-6b scores

Graph of PROMUS-PF-6b scores for physical functioning over 1 year

Quality of life

Mean PEmb-QOL scores

 Graph of Pemb-QOL scores for quality of life over 1 year
Filename
ekos-optalyse-clinical-trial.pdf
Size
748 KB
Format
application/pdf
Download the full OPTALYSE study

icon of open envelope with letter

Stay up to date

Receive emails on the latest advances, EKOS clinical data and news.

1. Tapson V et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism.  JACC: Cardiovascular Interventions 2018; 11(14):1401-1410.